{{ $ActivityName }}
Male Female
< 5 years
5-10 years
11-20 years
>20 years
Multi-specialty hospital
Clinic/ nursing home
Government hospital/ medical college
Mixed
Tier 1 city
Tier 2 city
Tier 3 city
Rural area
up to 25%
25-50%
50-75%
75-100%
Levocetirizine
Fexofenadine
Desloratadine
Bilastine
Long half life
less side effects
Better tolerated
Any other
Pruritus
Wheal number
Reducing angioedema
up to 20%
20-30%
30-50%
>50%
up to 10%
10-20%
30-40%
40-50%
Add cyclosporine
Add Omalizumab
Start Omalizumab plus cyclosporine